SYNOPSYS INC financials

  1. Home
  2. Financials
  3. SNPS
SNPS CIK 0000883241

Source: EDGAR filings · Built 2026-06-02T04:04:58Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.35B 1.27B 1.51B 1.60B 1.40B 836.60M
EBITDA 1.58B 1.65B 1.52B 1.38B 938.47M 830.13M
Working Capital 2.29B 3.82B 445.17M 238.17M 394.86M 409.30M
Net Debt 11.41B -3.21B -746.16M -761.24M -716.17M -572.16M
Gross Margin 76.98% 79.68% 80.62% 80.54% 79.50% 78.44%
Operating Margin 12.97% 22.13% 23.94% 24.89% 17.48% 16.83%
Net Margin 18.89% 36.94% 23.13% 21.33% 18.02% 18.03%
Return on Equity (ROE) 4.70% 25.17% 20.01% 17.85% 14.31% 13.54%
Return on Assets (ROA) 2.76% 17.31% 11.90% 10.45% 8.66% 8.27%
Current Ratio 1.62× 2.44× 1.15× 1.09× 1.16× 1.19×
Debt-to-Equity 0.50× 0.08× 0.11× 0.12× 0.14× 0.14×
Effective Tax Rate 4.02% 6.59% 6.91% 12.63% 6.10% -3.96%
Cash Conversion Ratio 1.14× 0.62× 1.38× 1.77× 1.97× 1.49×
Accruals Ratio -0.00× 0.07× -0.05× -0.08× -0.08× -0.04×
SBC % of Revenue 12.66% 11.30% 10.59% 9.94% 8.21% 6.75%
CapEx Coverage 8.96× 10.09× 8.98× 12.73× 15.92× 6.41×
Free Cash Flow Per Share $8.14 $8.13 $9.75 $10.24 $8.89 $5.37

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 56.45× 35.40× 59.27× 46.51× 69.27× 50.08×
P/FCF 55.72× 63.19× 48.13× 28.57× 37.48× 39.80×
FCF Yield 1.79% 1.58% 2.08% 3.50% 2.67% 2.51%
EV / EBITDA 60.82× 46.00× 46.46× 31.82× 53.58× 38.63×
P/S 11.97× 12.92× 13.42× 9.66× 12.13× 8.86×
P/B 2.98× 8.80× 11.61× 8.08× 9.63× 6.65×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 7.05B 6.13B 5.32B 4.62B 4.20B 3.69B
Revenues — — — 5.08B 4.20B 3.69B
Cost of Revenue 1.62B 1.25B 1.03B 898.01M 861.78M 794.69M
Gross Profit 5.43B 4.88B 4.29B 3.72B 3.34B 2.89B
Research and Development Expense 2.48B 2.08B 1.85B 1.59B 1.50B 1.28B
Operating Expenses 4.52B 3.53B 3.01B 2.57B 2.61B 2.27B
Operating Income (Loss) 914.93M 1.36B 1.27B 1.15B 734.79M 620.14M
Income Tax Expense (Benefit) 55.99M 99.72M 90.19M 139.38M 49.16M -25.29M
Net Income (Loss) Attributable to Parent 1.33B 2.26B 1.23B 984.59M 757.52M 664.35M
Earnings Per Share, Basic $8.13 $14.78 $8.08 $6.44 $4.96 $4.40
Weighted Average Number of Shares Outstanding, Basic 163.95M 153.14M 152.15M 153.00M 152.70M 151.13M
Earnings Per Share, Diluted $8.04 $14.51 $7.92 $6.29 $4.81 $4.27
Weighted Average Number of Shares Outstanding, Diluted 165.66M 155.94M 155.19M 156.49M 157.34M 155.71M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.89B 3.90B 1.43B 1.42B 1.43B 1.24B
Assets, Current 6.01B 6.47B 3.43B 3.01B 2.81B 2.55B
Assets 48.22B 13.07B 10.33B 9.42B 8.75B 8.03B
Long-term Debt 13.48B — — — — —
Liabilities, Current 3.72B 2.65B 2.99B 2.77B 2.41B 2.14B
Long-term Debt, Excluding Current Maturities 13.46B 15.60M 18.08M 20.82M 25.09M 100.82M
Liabilities 19.90B 4.05B 4.15B 3.86B 3.45B 3.12B
Stockholders' Equity Attributable to Parent 28.33B 8.99B 6.15B 5.52B 5.30B 4.91B
Common Stock, Shares, Outstanding 185.99M 154.11M 152.05M 152.38M 153.06M 152.62M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.52B 1.41B 1.70B 1.74B 1.49B 991.31M
Payments to Acquire Property, Plant, and Equipment 169.45M 139.50M 189.62M 136.59M 93.76M 154.72M
Net Cash Provided by (Used in) Investing Activities -15.88B 1.22B -482.10M -572.62M -549.03M -360.42M
Payments for Repurchase of Common Stock 0 0 1.16B 1.10B 753.08M 242.08M
Net Cash Provided by (Used in) Financing Activities 13.36B -181.30M -1.20B -1.12B -748.75M -140.61M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SNPS CIK 0000883241), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CVS

CVS HEALTH CORPORATION

MNKD

MannKind Corporation

UGI

UGI CORPORATION